APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Diltiazem

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Diltiazem Market Outlook and Growth Opportunities 2026

Report ID 173984880420 December 2025198 pages

Choose your research edition.

Industry ResearchDiltiazem Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Diltiazem Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Diltiazem Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diltiazem Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Diltiazem Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Diltiazem market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Diltiazem is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Diltiazem is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diltiazem is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Diltiazem market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Diltiazem market include Akorn, Athenex, Bausch Health, Hikma Pharmaceuticals, Par Pharmaceutical, Zydus Pharmaceuticals, Pfizer, Mylan and Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Diltiazem market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Diltiazem and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Diltiazem sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Diltiazem market size, projected growth trends, production technologies, key applications, and end-use industries.

Diltiazem Segment by Company

Akorn

Athenex

Bausch Health

Hikma Pharmaceuticals

Par Pharmaceutical

Zydus Pharmaceuticals

Pfizer

Mylan

Sandoz

Sun Pharma

Teva

Diltiazem Segment by Type

Injection

Tablet

Capsule

Diltiazem Segment by Application

Angina

Hypertension

Diltiazem Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Diltiazem status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Diltiazem market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Diltiazem significant trends, drivers, influence factors in global and regions.

6. To analyze Diltiazem competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diltiazem market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diltiazem and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diltiazem.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Diltiazem market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Diltiazem industry.

Chapter 3: Detailed analysis of Diltiazem manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Diltiazem in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Diltiazem in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Diltiazem Industry Trends Table 2. Diltiazem Industry Drivers Table 3. Diltiazem Industry Opportunities and Challenges Table 4. Diltiazem Industry Restraints Table 5. Global Diltiazem Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Diltiazem Revenue Share by Company (2021-2026) Table 7. Global Diltiazem Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Diltiazem Sales Volume Share by Company (2021-2026) Table 9. Global Diltiazem Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Diltiazem Company Ranking, (2024-2026) & (USD Million) Table 11. Global Diltiazem Key Company Manufacturing Base & Headquarters Table 12. Global Diltiazem Company, Product Type & Application Table 13. Global Diltiazem Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Diltiazem by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Table 18. Significant Companies of Tablet Table 19. Significant Companies of Capsule Table 20. Global Diltiazem Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Diltiazem Sales Volume by Type (2021-2026) & (W Units) Table 22. Global Diltiazem Sales Volume by Type (2027-2032) & (W Units) Table 23. Global Diltiazem Sales Volume Share by Type (2021-2026) Table 24. Global Diltiazem Sales Volume Share by Type (2027-2032) Table 25. Global Diltiazem Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Diltiazem Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Diltiazem Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Diltiazem Sales Value Share by Type (2021-2026) Table 29. Global Diltiazem Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Angina Table 31. Significant Companies of Hypertension Table 32. Global Diltiazem Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Diltiazem Sales Volume by Application (2021-2026) & (W Units) Table 34. Global Diltiazem Sales Volume by Application (2027-2032) & (W Units) Table 35. Global Diltiazem Sales Volume Share by Application (2021-2026) Table 36. Global Diltiazem Sales Volume Share by Application (2027-2032) Table 37. Global Diltiazem Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Diltiazem Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Diltiazem Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Diltiazem Sales Value Share by Application (2021-2026) Table 41. Global Diltiazem Sales Value Share by Application (2027-2032) Table 42. Global Diltiazem Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Diltiazem Sales by Region (2021-2026) & (W Units) Table 44. Global Diltiazem Sales Market Share by Region (2021-2026) Table 45. Global Diltiazem Sales by Region (2027-2032) & (W Units) Table 46. Global Diltiazem Sales Market Share by Region (2027-2032) Table 47. Global Diltiazem Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Diltiazem Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Diltiazem Sales Value Share by Region (2021-2026) Table 50. Global Diltiazem Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Diltiazem Sales Value Share by Region (2027-2032) Table 52. Global Diltiazem Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Diltiazem Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Diltiazem Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Global Diltiazem Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Diltiazem Sales by Country (2021-2026) & (W Units) Table 57. Global Diltiazem Sales Market Share by Country (2021-2026) Table 58. Global Diltiazem Sales by Country (2027-2032) & (W Units) Table 59. Global Diltiazem Sales Market Share by Country (2027-2032) Table 60. Global Diltiazem Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Diltiazem Sales Value Market Share by Country (2021-2026) Table 62. Global Diltiazem Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Diltiazem Sales Value Market Share by Country (2027-2032) Table 64. Akorn Company Information Table 65. Akorn Business Overview Table 66. Akorn Diltiazem Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Akorn Diltiazem Product Portfolio Table 68. Akorn Recent Development Table 69. Athenex Company Information Table 70. Athenex Business Overview Table 71. Athenex Diltiazem Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Athenex Diltiazem Product Portfolio Table 73. Athenex Recent Development Table 74. Bausch Health Company Information Table 75. Bausch Health Business Overview Table 76. Bausch Health Diltiazem Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Bausch Health Diltiazem Product Portfolio Table 78. Bausch Health Recent Development Table 79. Hikma Pharmaceuticals Company Information Table 80. Hikma Pharmaceuticals Business Overview Table 81. Hikma Pharmaceuticals Diltiazem Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Hikma Pharmaceuticals Diltiazem Product Portfolio Table 83. Hikma Pharmaceuticals Recent Development Table 84. Par Pharmaceutical Company Information Table 85. Par Pharmaceutical Business Overview Table 86. Par Pharmaceutical Diltiazem Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Par Pharmaceutical Diltiazem Product Portfolio Table 88. Par Pharmaceutical Recent Development Table 89. Zydus Pharmaceuticals Company Information Table 90. Zydus Pharmaceuticals Business Overview Table 91. Zydus Pharmaceuticals Diltiazem Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Zydus Pharmaceuticals Diltiazem Product Portfolio Table 93. Zydus Pharmaceuticals Recent Development Table 94. Pfizer Company Information Table 95. Pfizer Business Overview Table 96. Pfizer Diltiazem Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Pfizer Diltiazem Product Portfolio Table 98. Pfizer Recent Development Table 99. Mylan Company Information Table 100. Mylan Business Overview Table 101. Mylan Diltiazem Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Mylan Diltiazem Product Portfolio Table 103. Mylan Recent Development Table 104. Sandoz Company Information Table 105. Sandoz Business Overview Table 106. Sandoz Diltiazem Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Sandoz Diltiazem Product Portfolio Table 108. Sandoz Recent Development Table 109. Sun Pharma Company Information Table 110. Sun Pharma Business Overview Table 111. Sun Pharma Diltiazem Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Sun Pharma Diltiazem Product Portfolio Table 113. Sun Pharma Recent Development Table 114. Teva Company Information Table 115. Teva Business Overview Table 116. Teva Diltiazem Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Teva Diltiazem Product Portfolio Table 118. Teva Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Diltiazem Distributors List Table 122. Diltiazem Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Diltiazem Product Image Figure 2. Global Diltiazem Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diltiazem Sales Value (2021-2032) & (US$ Million) Figure 4. Global Diltiazem Sales (2021-2032) & (W Units) Figure 5. Global Diltiazem Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Diltiazem Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Image Figure 10. Tablet Image Figure 11. Capsule Image Figure 12. Global Diltiazem Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Diltiazem Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Diltiazem Sales Volume Share by Type (2021-2032) Figure 15. Global Diltiazem Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Diltiazem Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Diltiazem Sales Value Share by Type (2021-2032) Figure 18. Angina Image Figure 19. Hypertension Image Figure 20. Global Diltiazem Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Diltiazem Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Diltiazem Sales Volume Share by Application (2021-2032) Figure 23. Global Diltiazem Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Diltiazem Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Diltiazem Sales Value Share by Application (2021-2032) Figure 26. Global Diltiazem Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 27. Global Diltiazem Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Diltiazem Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Diltiazem Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Diltiazem Sales Value (2021-2032) & (US$ Million) Figure 31. North America Diltiazem Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Diltiazem Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Diltiazem Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Diltiazem Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Diltiazem Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Diltiazem Sales Value (2021-2032) & (US$ Million) Figure 37. South America Diltiazem Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Diltiazem Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Diltiazem Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Diltiazem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Diltiazem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Diltiazem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Diltiazem Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Diltiazem Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablet
  • Capsule
Applications
  • Angina
  • Hypertension
Companies covered
  • Akorn
  • Athenex
  • Bausch Health
  • Hikma Pharmaceuticals
  • Par Pharmaceutical
  • Zydus Pharmaceuticals
  • Pfizer
  • Mylan
  • Sandoz
  • Sun Pharma
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Diltiazem Sales Value (2021-2032)
  4. 1.2.2 Global Diltiazem Sales Volume (2021-2032)
  5. 1.2.3 Global Diltiazem Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Diltiazem Market Dynamics
  1. 2.1 Diltiazem Industry Trends
  2. 2.2 Diltiazem Industry Drivers
  3. 2.3 Diltiazem Industry Opportunities and Challenges
  4. 2.4 Diltiazem Industry Restraints
3 Diltiazem Market by Company
  1. 3.1 Global Diltiazem Company Revenue Ranking in 2025
  2. 3.2 Global Diltiazem Revenue by Company (2021-2026)
  3. 3.3 Global Diltiazem Sales Volume by Company (2021-2026)
  4. 3.4 Global Diltiazem Average Price by Company (2021-2026)
  5. 3.5 Global Diltiazem Company Ranking (2024-2026)
  6. 3.6 Global Diltiazem Company Manufacturing Base and Headquarters
  7. 3.7 Global Diltiazem Company Product Type and Application
  8. 3.8 Global Diltiazem Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Diltiazem Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Diltiazem Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Diltiazem Market by Type
  1. 4.1 Diltiazem Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Tablet
  4. 4.1.3 Capsule
  5. 4.2 Global Diltiazem Sales Volume by Type
  6. 4.2.1 Global Diltiazem Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Diltiazem Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Diltiazem Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Diltiazem Sales Value by Type
  10. 4.3.1 Global Diltiazem Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Diltiazem Sales Value by Type (2021-2032)
  12. 4.3.3 Global Diltiazem Sales Value Share by Type (2021-2032)
5 Diltiazem Market by Application
  1. 5.1 Diltiazem Application Introduction
  2. 5.1.1 Angina
  3. 5.1.2 Hypertension
  4. 5.2 Global Diltiazem Sales Volume by Application
  5. 5.2.1 Global Diltiazem Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Diltiazem Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Diltiazem Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Diltiazem Sales Value by Application
  9. 5.3.1 Global Diltiazem Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Diltiazem Sales Value by Application (2021-2032)
  11. 5.3.3 Global Diltiazem Sales Value Share by Application (2021-2032)
6 Diltiazem Regional Sales and Value Analysis
  1. 6.1 Global Diltiazem Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Diltiazem Sales by Region (2021-2032)
  3. 6.2.1 Global Diltiazem Sales by Region: 2021-2026
  4. 6.2.2 Global Diltiazem Sales by Region (2027-2032)
  5. 6.3 Global Diltiazem Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Diltiazem Sales Value by Region (2021-2032)
  7. 6.4.1 Global Diltiazem Sales Value by Region: 2021-2026
  8. 6.4.2 Global Diltiazem Sales Value by Region (2027-2032)
  9. 6.5 Global Diltiazem Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Diltiazem Sales Value (2021-2032)
  12. 6.6.2 North America Diltiazem Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Diltiazem Sales Value (2021-2032)
  15. 6.7.2 Europe Diltiazem Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Diltiazem Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Diltiazem Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Diltiazem Sales Value (2021-2032)
  21. 6.9.2 South America Diltiazem Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Diltiazem Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Diltiazem Sales Value Share by Country, 2025 VS 2032
7 Diltiazem Country-level Sales and Value Analysis
  1. 7.1 Global Diltiazem Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Diltiazem Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Diltiazem Sales by Country (2021-2032)
  4. 7.3.1 Global Diltiazem Sales by Country (2021-2026)
  5. 7.3.2 Global Diltiazem Sales by Country (2027-2032)
  6. 7.4 Global Diltiazem Sales Value by Country (2021-2032)
  7. 7.4.1 Global Diltiazem Sales Value by Country (2021-2026)
  8. 7.4.2 Global Diltiazem Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Diltiazem Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Diltiazem Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Diltiazem Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Diltiazem Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Diltiazem Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Diltiazem Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Diltiazem Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Diltiazem Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Diltiazem Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Diltiazem Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Diltiazem Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Diltiazem Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Diltiazem Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Diltiazem Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Diltiazem Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Diltiazem Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Diltiazem Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Diltiazem Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Diltiazem Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Diltiazem Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Diltiazem Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Diltiazem Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Diltiazem Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Diltiazem Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Diltiazem Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Diltiazem Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Diltiazem Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Diltiazem Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Diltiazem Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Diltiazem Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Diltiazem Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Diltiazem Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Diltiazem Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Diltiazem Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Diltiazem Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Diltiazem Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Diltiazem Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Diltiazem Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Diltiazem Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Diltiazem Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Diltiazem Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Diltiazem Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Diltiazem Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Diltiazem Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Diltiazem Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Diltiazem Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Diltiazem Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Diltiazem Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Diltiazem Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Diltiazem Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Diltiazem Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Diltiazem Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Diltiazem Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Diltiazem Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Diltiazem Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Diltiazem Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Diltiazem Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Diltiazem Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Diltiazem Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Diltiazem Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Diltiazem Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Diltiazem Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Diltiazem Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Diltiazem Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Diltiazem Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Diltiazem Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Diltiazem Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Diltiazem Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Diltiazem Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Diltiazem Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Diltiazem Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Diltiazem Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Diltiazem Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Diltiazem Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Diltiazem Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Diltiazem Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Diltiazem Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Diltiazem Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Diltiazem Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Diltiazem Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Diltiazem Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Diltiazem Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Diltiazem Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Diltiazem Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Akorn
  2. 8.1.1 Akorn Company Information
  3. 8.1.2 Akorn Business Overview
  4. 8.1.3 Akorn Diltiazem Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Akorn Diltiazem Product Portfolio
  6. 8.1.5 Akorn Recent Developments
  7. 8.2 Athenex
  8. 8.2.1 Athenex Company Information
  9. 8.2.2 Athenex Business Overview
  10. 8.2.3 Athenex Diltiazem Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Athenex Diltiazem Product Portfolio
  12. 8.2.5 Athenex Recent Developments
  13. 8.3 Bausch Health
  14. 8.3.1 Bausch Health Company Information
  15. 8.3.2 Bausch Health Business Overview
  16. 8.3.3 Bausch Health Diltiazem Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bausch Health Diltiazem Product Portfolio
  18. 8.3.5 Bausch Health Recent Developments
  19. 8.4 Hikma Pharmaceuticals
  20. 8.4.1 Hikma Pharmaceuticals Company Information
  21. 8.4.2 Hikma Pharmaceuticals Business Overview
  22. 8.4.3 Hikma Pharmaceuticals Diltiazem Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hikma Pharmaceuticals Diltiazem Product Portfolio
  24. 8.4.5 Hikma Pharmaceuticals Recent Developments
  25. 8.5 Par Pharmaceutical
  26. 8.5.1 Par Pharmaceutical Company Information
  27. 8.5.2 Par Pharmaceutical Business Overview
  28. 8.5.3 Par Pharmaceutical Diltiazem Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Par Pharmaceutical Diltiazem Product Portfolio
  30. 8.5.5 Par Pharmaceutical Recent Developments
  31. 8.6 Zydus Pharmaceuticals
  32. 8.6.1 Zydus Pharmaceuticals Company Information
  33. 8.6.2 Zydus Pharmaceuticals Business Overview
  34. 8.6.3 Zydus Pharmaceuticals Diltiazem Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Zydus Pharmaceuticals Diltiazem Product Portfolio
  36. 8.6.5 Zydus Pharmaceuticals Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Diltiazem Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Diltiazem Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Mylan
  44. 8.8.1 Mylan Company Information
  45. 8.8.2 Mylan Business Overview
  46. 8.8.3 Mylan Diltiazem Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Mylan Diltiazem Product Portfolio
  48. 8.8.5 Mylan Recent Developments
  49. 8.9 Sandoz
  50. 8.9.1 Sandoz Company Information
  51. 8.9.2 Sandoz Business Overview
  52. 8.9.3 Sandoz Diltiazem Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sandoz Diltiazem Product Portfolio
  54. 8.9.5 Sandoz Recent Developments
  55. 8.10 Sun Pharma
  56. 8.10.1 Sun Pharma Company Information
  57. 8.10.2 Sun Pharma Business Overview
  58. 8.10.3 Sun Pharma Diltiazem Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sun Pharma Diltiazem Product Portfolio
  60. 8.10.5 Sun Pharma Recent Developments
  61. 8.11 Teva
  62. 8.11.1 Teva Company Information
  63. 8.11.2 Teva Business Overview
  64. 8.11.3 Teva Diltiazem Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Teva Diltiazem Product Portfolio
  66. 8.11.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Diltiazem Value Chain Analysis
  2. 9.1.1 Diltiazem Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Diltiazem Sales Mode & Process
  6. 9.2 Diltiazem Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Diltiazem Distributors
  9. 9.2.3 Diltiazem Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst